Literature DB >> 27413110

Editor's Highlight: Neonatal Activation of the Xenobiotic-Sensors PXR and CAR Results in Acute and Persistent Down-regulation of PPARα-Signaling in Mouse Liver.

Cindy Yanfei Li1, Sunny Lihua Cheng1, Theo K Bammler1, Julia Yue Cui2.   

Abstract

Safety concerns have emerged regarding the potential long-lasting effects due to developmental exposure to xenobiotics. The pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are critical xenobiotic-sensing nuclear receptors that are highly expressed in liver. The goal of this study was to test our hypothesis that neonatal exposure to PXR- or CAR-activators not only acutely but also persistently regulates the expression of drug-processing genes (DPGs). A single dose of the PXR-ligand PCN (75 mg/kg), CAR-ligand TCPOBOP (3 mg/kg), or vehicle (corn oil) was administered intraperitoneally to 3-day-old neonatal wild-type mice. Livers were collected 24 h post-dose or from adult mice at 60 days of age, and global gene expression of these mice was determined using Affymetrix Mouse Transcriptome Assay 1.0. In neonatal liver, PCN up-regulated 464 and down-regulated 449 genes, whereas TCPOBOP up-regulated 308 and down-regulated 112 genes. In adult liver, there were 15 persistently up-regulated and 22 persistently down-regulated genes following neonatal exposure to PCN, as well as 130 persistently up-regulated and 18 persistently down-regulated genes following neonatal exposure to TCPOBOP. Neonatal exposure to both PCN and TCPOBOP persistently down-regulated multiple Cyp4a members, which are prototypical-target genes of the lipid-sensor PPARα, and this correlated with decreased PPARα-binding to the Cyp4a gene loci. RT-qPCR, western blotting, and enzyme activity assays in livers of wild-type, PXR-null, and CAR-null mice confirmed that the persistent down-regulation of Cyp4a was PXR and CAR dependent. In conclusion, neonatal exposure to PXR- and CAR-activators both acutely and persistently regulates critical genes involved in xenobiotic and lipid metabolism in liver.
© The Author 2016. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CAR; PPARα; PXR; drug-processing genes; neonatal exposure

Mesh:

Substances:

Year:  2016        PMID: 27413110      PMCID: PMC5036618          DOI: 10.1093/toxsci/kfw127

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  57 in total

1.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.

Authors:  P Wei; J Zhang; M Egan-Hafley; S Liang; D D Moore
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 2.  CAR, driving into the future.

Authors:  Karen Swales; Masahiko Negishi
Journal:  Mol Endocrinol       Date:  2004-02-26

3.  Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice.

Authors:  Julia Yue Cui; Helen J Renaud; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

4.  CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.

Authors:  Martin Wagner; Emina Halilbasic; Hanns-Ulrich Marschall; Gernot Zollner; Peter Fickert; Cord Langner; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

Review 5.  PXR and CAR in energy metabolism.

Authors:  Taira Wada; Jie Gao; Wen Xie
Journal:  Trends Endocrinol Metab       Date:  2009-08       Impact factor: 12.015

Review 6.  Functional and structural comparison of PXR and CAR.

Authors:  John T Moore; Linda B Moore; Jodi M Maglich; Steve A Kliewer
Journal:  Biochim Biophys Acta       Date:  2003-02-17

7.  Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation.

Authors:  Ji Miao; Zhen Xiao; Deepthi Kanamaluru; Gyesik Min; Peter M Yau; Timothy D Veenstra; Ewa Ellis; Steve Strom; Kelly Suino-Powell; H Eric Xu; Jongsook Kim Kemper
Journal:  Genes Dev       Date:  2009-04-15       Impact factor: 11.361

8.  Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha.

Authors:  Ji Miao; Sungsoon Fang; Yangjin Bae; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

9.  Biochemical characterization of the hepatic effects in mice and rats of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, a hepatic neoplasm promoter.

Authors:  M Romano; A Esteve; P Coccia; P Masturzo; G Galliani; P Ghezzi; M Salmona
Journal:  Toxicol Appl Pharmacol       Date:  1986-04       Impact factor: 4.219

Review 10.  PPARalpha in atherosclerosis and inflammation.

Authors:  Fokko Zandbergen; Jorge Plutzky
Journal:  Biochim Biophys Acta       Date:  2007-05-21
View more
  8 in total

1.  Consequences of Phenytoin Exposure on Hepatic Cytochrome P450 Expression during Postnatal Liver Maturation in Mice.

Authors:  Stephanie C Piekos; Liming Chen; Pengcheng Wang; Jian Shi; Sharon Yaqoob; Hao-Jie Zhu; Xiaochao Ma; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2018-06-08       Impact factor: 3.922

2.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

3.  Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life.

Authors:  Stephanie Piekos; Chad Pope; Austin Ferrara; Xiao-Bo Zhong
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

4.  RNA Sequencing Reveals Age and Species Differences of Constitutive Androstane Receptor-Targeted Drug-Processing Genes in the Liver.

Authors:  Sunny Lihua Cheng; Theo K Bammler; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2017-02-23       Impact factor: 3.922

5.  Regulation of protein-coding gene and long noncoding RNA pairs in liver of conventional and germ-free mice following oral PBDE exposure.

Authors:  Cindy Yanfei Li; Julia Yue Cui
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

Review 6.  Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR.

Authors:  Jenni Küblbeck; Jonna Niskanen; Paavo Honkakoski
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

Review 7.  Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets.

Authors:  Jie Liu; Yun Shi; Daiyin Peng; Lei Wang; Nianjun Yu; Guokai Wang; Weidong Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-22

8.  Transcriptomic analysis across liver diseases reveals disease-modulating activation of constitutive androstane receptor in cholestasis.

Authors:  Bhoomika Mathur; Waqar Arif; Megan E Patton; Rahiman Faiyaz; Jian Liu; Jennifer Yeh; Sanjiv Harpavat; Kristina Schoonjans; Auinash Kalsotra; Antony M Wheatley; Sayeepriyadarshini Anakk
Journal:  JHEP Rep       Date:  2020-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.